Showing 561 - 580 results of 122,967 for search '(( 10 mean decrease ) OR ( 5 ((((non decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.73s Refine Results
  1. 561
  2. 562

    Overexpression of human PGRN mRNA prevents the decrease in axon outgrowth produced by knockdown of zebrafish PGRN. by Angela S. Laird (360986)

    Published 2013
    “…<p>A) The decreased axonal length produced by knockdown of <i>grna</i> with a 5′UTR MO was rescued by co-expression of PGRN mRNA. * significantly different from grna CO MO, p<0.02; ̂ significantly different from <i>grna</i> MO + GFP, p<0.0001. …”
  3. 563
  4. 564

    Transforming growth factor (TGF)-β1 induced a robust decrease in S-phase in non-cancer cell strains by Kimberly A Brown (26546)

    Published 2011
    “…Representative histograms are presented illustrating cells that had a robust decrease in S-phase (NMuMG), modest decrease in S-phase (EpH4), and no decrease in S-phase (MDA-MB-436) as a result of TGF-βtreatment. …”
  5. 565
  6. 566
  7. 567
  8. 568

    Shortening of mTL anticipates accumulation of DDR markers, decrease in cell proliferation and increase in apoptotis with age. by Madalena C. Carneiro (102302)

    Published 2016
    “…Proliferative tissues, A) gut B) kidney marrow and C) testis, show a sustained decrease in cell proliferation by 12 months of age in <i>tert</i><sup><i>-/-</i></sup> (panels g, i) and by 36 months in WT tissues (panels f, h and j). …”
  9. 569
  10. 570
  11. 571
  12. 572

    <i>In vivo</i> treatment with entinostat decreases Foxp3 expression in Tregs and inhibits Tregs function. by Li Shen (110858)

    Published 2012
    “…Cells were harvested from spleens and lymph nodes. A, <i>In vivo</i> entinostat treatment decreased the expression level of Foxp3 in CD4<sup>+</sup>Foxp3<sup>+</sup> (Treg) cells. …”
  13. 573
  14. 574
  15. 575
  16. 576
  17. 577
  18. 578
  19. 579
  20. 580